Fate Therapeutics Inc.

NASDAQ: FATE · Real-Time Price · USD
1.09
0.02 (1.87%)
At close: Aug 15, 2025, 3:59 PM
1.14
4.11%
After-hours: Aug 15, 2025, 07:57 PM EDT

Fate Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.01 -2.29 -3.47 -26.13
PEG Ratio
n/a 0.05 -0.12 -3.92
PS Ratio
13.76 5.79 10.15 99.27
PB Ratio
0.59 1.00 2.02 8.17
P/FCF Ratio
-1.52 -2.66 -3.44 -25.96
P/OCF Ratio
-1.53 -2.78 -3.94 -34.04
OCF/S Ratio
-9.01 -2.08 -2.58 -2.92
Debt / Equity Ratio
0.27 0.28 0.23 0.17
Quick Ratio
7.58 8.48 4.40 7.79
Current Ratio
7.58 8.48 4.40 7.79
Asset Turnover
0.03 0.13 0.14 0.06
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-0.58 -0.44 -0.58 -0.31
Return on Assets
-0.42 -0.32 -0.4 -0.23
Return on Invested Capital
-0.5 -0.4 -0.46 -0.25
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 -1.47 0.86 0.90
Net Profit Margin
-13.66 -2.53 -2.93 -3.8
Pretax Profit Margin
-13.66 -2.53 -2.93 -3.8
Operating Profit Margin
-15.43 -3 -3.2 -3.89
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-12.95 -2.71 -3.06 -3.78